Article

Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice.

Washington University School of Medicine, Department of Internal Medicine, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.
American Journal Of Pathology (Impact Factor: 4.6). 05/2008; 172(4):868-81. DOI: 10.2353/ajpath.2008.070756
Source: PubMed

ABSTRACT Phospholipases A(2) (PLA(2)) hydrolyze the sn-2 fatty acid substituent, such as arachidonic acid, from phospholipids, and arachidonate metabolites are recognized mediators of bone modeling. We have previously generated knockout (KO) mice lacking the group VIA PLA(2) (iPLA(2)beta), which participates in a variety of signaling events; iPLA(2)beta mRNA is expressed in bones of wild-type (WT) but not KO mice. Cortical bone size, trabecular bone volume, bone mineralizing surfaces, and bone strength are similar in WT and KO mice at 3 months and decline with age in both groups, but the decreases are more pronounced in KO mice. The lower bone mass phenotype observed in KO mice is not associated with an increase in osteoclast abundance/activity or a decrease in osteoblast density, but is accompanied by an increase in bone marrow fat. Relative to WT mice, undifferentiated bone marrow stromal cells (BMSCs) from KO mice express higher levels of PPAR-gamma and lower levels of Runx2 mRNA, and this correlates with increased adipogenesis and decreased osteogenesis in BMSCs from these mice. In summary, our studies indicate that age-related losses in bone mass and strength are accelerated in iPLA(2)beta-null mice. Because adipocytes and osteoblasts share a common mesenchymal stem cell origin, our findings suggest that absence of iPLA(2)beta causes abnormalities in osteoblast function and BMSC differentiation and identify a previously unrecognized role of iPLA(2)beta in bone formation.

Download full-text

Full-text

Available from: Kevin E Yarasheski, Jan 08, 2014
0 Followers
 · 
357 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: An analytic model for the investigation of non-linear dynamics in boiling systems has been developed. This model is comprised of a nodal formulation that uses one-dimensional homogeneous equilibrium assumptions for diabatic two-phase flow, a lumped parameter approach for heated wall dynamics, and point neutron kinetics for the consideration of nuclear feedback in a boiling water reactor (BWR) loop. This model indicates that a boiling channel coupled with a riser may experience chaotic oscillations. In contrast, a boiling channel without a riser that is subjected to a constant pressure drop (i.e. a parallel channel) may undergo a supercritical bifurcation (i.e. may experience a limit cycle), but chaos was not found. Flow instabilities in a two-phase natural circulation loop have been verified using the model presented in this paper. The predictions of the effects of the channel inlet resistance, outlet resistance and liquid level in the downcomer agree with the data of Kyung and Lee. Finally, an analysis of nuclear-coupled density-wave instabilities in a simplified BWR (SBWR) was performed. Significantly, even for low pressure conditions, a simplified SBWR appears to be stable during start-up and normal operations; however, a limit cycle may occur for abnormal operating conditions.
    Nuclear Engineering and Design 04/1997; 167(3):307-334. DOI:10.1016/S0029-5493(96)01299-X · 0.97 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Phospholipase A(2) (PLA(2)) are esterases that cleave glycerophospholipids to release fatty acids and lysophospholipids. Several studies demonstrate that PLA(2) regulate growth and signaling in several cell types. However, few of these studies have focused on Ca2+-independent phospholipase A(2) (iPLA(2) or Group VI PLA(2)). This class of PLA(2) was originally suggested to mediate phospholipid remodeling in several cell types including macrophages. As such, it was labeled as a housekeeping protein and thought not to play as significant of roles in cell growth as its older counterparts cytosolic PLA(2) (cPLA(2) or Group IV PLA(2)) and secretory PLA(2) (sPLA(2) or Groups I-III, V and IX-XIV PLA(2)). However, several recent studies demonstrate that iPLA(2) mediate cell growth, and do so by participating in signal transduction pathways that include epidermal growth factor receptors (EGFR), mitogen activated protein kinases (MAPK), mdm2, and even the tumor suppressor protein p53 and the cell cycle regulator p21. The exact mechanism by which iPLA(2) mediates these pathways are not known, but likely involve the generation of lipid signals such as arachidonic acid, lysophosphatidic acid (LPA) and lysophosphocholines (LPC). This review discusses the role of iPLA(2) in cell growth with special emphasis placed on their role in cell signaling. The putative lipid signals involved are also discussed.
    Biochemical pharmacology 09/2008; 76(9):1059-67. DOI:10.1016/j.bcp.2008.07.044 · 4.65 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Tremendous advances in understanding the structure and function of the superfamily of phospholipase A2 (PLA2) enzymes has occurred in the twenty-first century. The superfamily includes 15 groups comprising four main types including the secreted sPLA2, cytosolic cPLA2, calcium-independent iPLA2, and platelet activating factor (PAF) acetyl hydrolase/oxidized lipid lipoprotein associated (Lp)PLA2. We review herein our current understanding of the structure and interaction with substrate phospholipids, which resides in membranes for a representative of each of these main types of PLA2. We will also briefly review the development of inhibitors of these enzymes and their roles in lipid signaling.
    The Journal of Lipid Research 12/2008; 50 Suppl:S237-42. DOI:10.1194/jlr.R800033-JLR200 · 4.73 Impact Factor